Picture of Compumedics logo

CMP Compumedics Income Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSuper Stock

Annual income statement for Compumedics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue41.535.135.737.842.4
Cost of Revenue
Gross Profit24.81819.219.321.6
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses36.242.233.835.848.5
Operating Profit5.35-7.081.911.93-6.11
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes5.09-7.50.7761.7-6.72
Provision for Income Taxes
Net Income After Taxes4.02-5.840.9981.36-6.12
Net Income Before Extraordinary Items
Net Income4.02-5.840.9981.36-6.12
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income4.02-5.840.9981.36-6.12
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.023-0.0080.0020.003-0.023